Fertility rapid tests are conducted to detect infertility issues in men and women. Fertility rapid tests provide impotence results of a man and infertility results of a woman. Whereas, pregnancy rapid tests identify the presence of pregnancy hormone, named human chorionic gonadotropin hormone (HCG), through woman’s blood or urine. Unplanned pregnancy rate and the prevalence of infertility issues across the world are the prominent factors which drive the global fertility and pregnancy rapid test market. A 2014 report by Guttmatcher institute suggested that 615,000 US women aged 15 to 19 become pregnant each year, while 82% of these pregnancies are unwanted. In developing countries like India, 76 girls out of 1000, aged 15-19 become pregnant each year.
Fertility and Pregnancy Rapid Tests Market: Drivers & Restraints
The global Fertility and pregnancy rapid tests market is expected to grow at a significant growth rate in the forecast period (2012-2025) due to the accurate and rapid results provided by these tests and innovation in test kits. With rising incidences of infertility in the reproductive system of women and men, rising birth rates in middle and low income countries and increasing awareness in the masses is expected to provide impetus to the global fertility and pregnancy rapid test market. Also, the changing lifestyles of the developed region population and consecutive disorders are likely to boost the fertility and pregnancy rapid test market.

Request free sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-607
Fertility and Pregnancy Rapid Tests Market: Segmentation
The global Fertility and Pregnancy Rapid Tests Marketis broadly classified into two segments based on the types of fertility rapid tests as follows:
Follicle Stimulating Hormone (FSH) Tests
Luteinizing Hormone (LH) Tests
The global Fertility and Pregnancy Rapid Tests Marketis segmented based on the type of pregnancy rapid tests as follows:
Human Chorionic Gonadotropin Hormone (HCG) Tests for Blood
Human Chorionic Gonadotropin Hormone (HCG) Tests for Urine/ Home Pregnancy Tests (HPT)
Human chorionic gonadotropin hormone (HCG) tests segment is anticipated to account for majority of the global fertility and pregnancy rapid tests market, as they are private, inexpensive, easy to use and highly accurate if used correctly.

Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-607

Fertility and Pregnancy Rapid Test Market: Regional Outlook
The global fertility and pregnancy rapid tests market is expected to show considerable growth with a single digit CAGR. Depending on geographic regions, global fertility and pregnancy rapid tests market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America dominated the global fertility and pregnancy rapid test market in terms of revenue owing to the advanced techniques and innovation in fertility and pregnancy rapid test kits, such as advanced week estimator, advanced SpermCheck Fertility kits etc. The middle and low income countries in Asia-pacific region are anticipated to show a great opportunity for the fertility and pregnancy rapid tests market.

Browse full report: http://www.futuremarketinsights.com/reports/fertility-and-pregnancy-rapid-tests-market
Fertility and Pregnancy Rapid Test Market: Key Players
The key players in global fertility and pregnancy rapid test market are Alere, Atlas medical, SA Scientific, bioMérieux, Craig medical, Gemc Technologies (Zhengzhou) co., ltd, First Response, Egens, Diagnostic Automation / Cortez Diagnostics, Inc.